We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By continuing to use our site, you accept our use of Cookies, Privacy Policy Term of use.
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
6,600 views • May 19, 2022
video privacyUnlisted

Rare Blood Clotting Disorder from J&J Vaccine Cause FDA to Limit It’s Use | Facts Matter

Facts Matter
Facts Matter
Over the past two years, people across this country were censored, suspended, and even banned from social media for questioning the potential side-effects of the vaccine. Many people were also fired from their workplace if they refused to take it. However, the FDA just released an official statement announcing that it will be severely restricting the use of the Johnson & Johnson vaccine, due to serious concerns of a blood clotting disorder. Specifically, due to a disorder called thrombosis with thrombocytopenia syndrome (TTS), the FDA has decided to almost entirely shelve the Johnson & Johnson vaccine, except in special situations. What’s the cause behind this? And what are the large implications? -- Stay tuned for our newsletter so you won’t miss out on our exclusive videos and private events. Follow Roman on Instagram: @epoch.times.roman Listen to Podcasts: iTunes Podcast: https://ept.ms/FactsMatterApplePodcast Spotify Podcast: https://ept.ms/FactsMatterSpotifyPodcast Google Podcast: https://ept.ms/FactsMatterGooglePodcast Follow EpochTV on social media: Facebook: https://www.facebook.com/EpochTVus Twitter: https://twitter.com/EpochTVus Rumble: https://rumble.com/c/EpochTV Gettr: https://gettr.com/user/epochtv Gab: https://gab.com/EpochTV Telegram: https://t.me/EpochTV Parler: https://parler.com/#/user/EpochTV
Show All
Comment 0